Quote | Oncotelic Therapeutics Inc (OTCMKTS:OTLC)
Last: | $0.032 |
---|---|
Change Percent: | 0.0% |
Open: | $0.031 |
Close: | $0.032 |
High: | $0.032 |
Low: | $0.0305 |
Volume: | 4,000 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Oncotelic Therapeutics Inc (OTCMKTS:OTLC)
AGOURA HILLS, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will speak at the 20th Annual Congress of International Drug Discovery Science & Technology (IDDST) (Europe), June 17-19, 2024 at Budapest, Hungary. ...
AGOURA HILLS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will be participating at the BIO International 2024 meeting on June3-6, San Diego. The BIO International Convention is the largest and most comprehensive event ...
Message Board Posts | Oncotelic Therapeutics Inc (OTCMKTS:OTLC)
Subject | By | Source | When |
---|---|---|---|
$OTLC Oncotelic Therapeutics Inc (QB) | mick | investorshub | 04/30/2023 10:14:49 PM |
$OTLC Oncotelic Therapeutics Inc (QB) | mick | investorshub | 04/15/2023 6:22:59 PM |
Oncotelic Announces Release of Pet2DAO Tokens (PDAO): https://www.benzinga. | mishe | investorshub | 04/06/2023 2:43:45 AM |
panda448: Oncotelic Announces Release of Pet2DAO Tokens (PDAO): https://www.benzinga.com/pressreleas | panda448 | investorshangout | 04/06/2023 12:42:29 AM |
Oncotelic Announces Release of Pet2DAO Tokens (PDAO): https://www.benzinga.com/pressreleases/23 | | mwn | 04/05/2023 10:41:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Oncotelic Therapeutics Inc Company Name:
OTLC Stock Symbol:
OTCMKTS Market:
Oncotelic Therapeutics Inc Website:
AGOURA HILLS, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will speak at the 20th Annual Congress of International Drug Discovery Science & Technology (IDDST) (Europe), June 17-19, 2024 at Budapest, Hungary. ...
AGOURA HILLS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu will be participating at the BIO International 2024 meeting on June3-6, San Diego. The BIO International Convention is the largest and most comprehensive event ...
AGOURA HILLS, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024 meeting. Abstract: e16318. Meta-analysis comparing the incidence of serious adverse events, ov...